Changeflow GovPing Healthcare & Life Sciences Parkinson's Dynamic Standing Desk Pilot Study, ...
Routine Notice Added Final

Parkinson's Dynamic Standing Desk Pilot Study, 12 Sessions

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered a Phase 1 pilot study (NCT07543861) evaluating dynamic standing desk use in Parkinson's disease patients over 12 sessions, each lasting 4 hours. The study tests the primary hypothesis that dynamic standing improves gait function compared to static standing and control sitting, with Phase 1 as open-label and Phase 2 as an in-lab randomized controlled trial. This registry entry documents study parameters, condition (Parkinson Disease), and intervention (Dynamic Standing Desk) without imposing compliance obligations.

“12 4-hour sessions will be performed to test the primary hypothesis that dynamic standing improves gait function compared to static standing and control sitting.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 686 changes logged to date.

What changed

NIH published a clinical trial registration for a Phase 1 open-label pilot study examining the user experience of dynamic standing desks in Parkinson's disease patients, with 12 sessions of 4 hours each. The study aims to test whether dynamic standing improves gait function compared to static standing and control sitting. Phase 2 will be conducted as an in-lab randomized controlled trial. This document is an informational registry entry; it does not create compliance obligations or regulatory requirements for any party. Healthcare providers and clinical investigators conducting similar gait or mobility intervention studies should note this as research context rather than guidance.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease

Phase 1 NCT07543861 Kind: PHASE1 Apr 22, 2026

Abstract

This research is studying the use of a new type of standing desk in a small number of people to learn about the user experience for people with Parkinson's disease. 12 4-hour sessions will be performed to test the primary hypothesis that dynamic standing improves gait function compared to static standing and control sitting. This study has 2 phases. Phase 1 will be an open-label study and Phase 2 will be an in-lab randomized controlled trial pilot study. This is phase 1 of the study.

Conditions: Parkinson Disease

Interventions: Dynamic Standing Desk

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Movement disorder research Mobility intervention study
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!